Melinta Therapeutics, Inc.

Company

• Pre-filing annual sales: $111 (millions of current dollars)
• Pre-filing assets: $510 (millions of current dollars)
• Pre-filing number of employees: 290
• Sub-industry: 28 Chemicals and Allied Products
• Place of incorporation: DE
• Court for city of headquarters: NJ Newark
• In business at filing? yes

Bankruptcy case

• Chapter at filing: Chapter 11
• Who filed case? debtors
• Debtor's lead attorney: Skadden Arps
• Date of filing: December 27, 2019
• Judge at filing: Laurie Selber Silverstein
• Court district of filing: DE
• Court city of filing: Wilmington
• Case number: 19-12748
• Cause of bankruptcy: Not tort
• Forum shop? Forum Shop


• Case transferred? no
• Destination court of transfer: not applicable
• Creditors committee appointed? yes
• §363 sale: no 363 sale
• Dip loan final approval? no
• Plan type: prenegotiated


• Disposition status: confirmed
• Date of disposition: April 11, 2020
• Judge at disposition: Laurie Selber Silverstein
• Days from filing to disposition: 106

After the case

• Did firm emerge? Company emerged
• Did firm refile? not emerged 5 years